For decades, medicine has spoken the language of hazard ratios, Kaplan-Meier curves, and median survival differences. We have become fluent in the grammar of precision oncology, genomic signatures, driver mutations, targeted therapeutics, and real-time disease monitoring. But there is one language we have not yet mastered: the language of the patient’s lived experience.Personalized medicine cannot […]
